A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Carisoprodol Screen, with Confirmation, Urine
Test Code90578
CPT Codes
80307
Includes
If Carisoprodol Screen is positive, Carisoprodol Metabolite, Quantitative, Urine will be performed at an additional charge (CPT code(s): 80358; G0480).
Preferred Specimen
10 mL random urine collected in a plastic urine container
Minimum Volume
2 mL
Transport Container
Plastic urine container
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 28 days
Refrigerated: 28 days
Frozen: 28 days
Refrigerated: 28 days
Frozen: 28 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Preserved samples
Methodology
Screen: Immunoassay (IA) • Confirmation: Liquid Chromatography/Tandem Mass Spectrometry (LC/MS/MS)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
2: 00 p. M. Tues, fri
Report Available
1-4 days
Reference Range
Carisoprodol Screen | Negative |
Clinical Significance
Carisoprodol is a muscle relaxant often used in the treatment of back pain. The drug has some potential for abuse. This test will aid the physician in monitoring therapeutic compliance.
Performing Laboratory
Quest Diagnostics Nichols Institute-Valencia |
8407 Fallbrook Ave, Suite 100 |
West Hills, CA 91304-3226 |
Last Updated: November 6, 2024